Ginkgo Bioworks DNA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 6.13 | 93.74 | -1.39 | -71,374 | -83 | |
| 2025Q4 | 8.31 | 86.81 | -1.42 | -70,046 | -81 | |
| 2025Q3 | 14.58 | 111.47 | -1.45 | -90,017 | -81 | |
| 2025Q2 | 11.25 | 107.78 | -2.77 | -73,537 | -60 | |
| 2025Q1 | 5.7 | 97.91 | -1.68 | -88,968 | -91 | |
| 2024Q4 | 9.82 | 96.14 | -1.96 | -103,606 | -108 | |
| 2024Q3 | 8.15 | 97.23 | -1.02 | -55,204 | -56 | |
| 2024Q2 | 13.37 | 102.74 | -4.24 | -222,945 | -217 | |
| 2024Q1 | 46.4 | 107.31 | -3.32 | -178,002 | -166 | |
| 2023Q4 | 67.6 | 84.54 | -4.28 | -178,117 | -212 | |
| 2023Q3 | 72.4 | 94.55 | -6.09 | -286,393 | -303 | |
| 2023Q2 | 74.4 | 106.33 | -3.6 | -184,151 | -173 | |
| 2023Q1 | 53.2 | 106.05 | -4.4 | -215,745 | -205 | |
| 2022Q4 | 67.6 | 116.75 | -2.6 | -230,864 | -175 | |
| 2022Q3 | 124.8 | 99.67 | -16.4 | -651,294 | -669 | |
| 2022Q2 | 95.2 | 97.63 | -16.4 | -646,052 | -669 | |
| 2022Q1 | 161.2 | 118.03 | -14.8 | -674,515 | -591 | |
| 2021Q4 | 332.4 | 105.29 | -48.4 | -1,684,735 | -1,601 | |
| 2021Q3 | 463.6 | 42.96 | -3.2 | -26,672 | -102 | |
| 2021Q2 | 4.97 | -1.6 | -5,311 | -107 |